MAO inhibitors

August 14, 2023

Depletion of dopamine in Parkinson’s disease and relevant therapeutic options: A review of the literature

Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects motor and cognition functions. The etiology of Parkinson’s disease…

April 23, 2023

Chemical and Biological Evaluation of Novel 1H-Chromeno[3,2-c]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer Activity

Abstract About twenty molecules sharing 1H-chromeno[3,2-c]pyridine as the scaffold and differing in the degree of saturation of the pyridine ring,…

June 26, 2021

Prolonged efavirenz exposure reduces peripheral oxytocin and vasopressin comparable to known drugs of addiction in male Sprague Dawley rats

Abstract Introduction: Several drugs of abuse (DOA) are capable of modulating neurohypophysial hormones, such as oxytocin (OT) and vasopressin (VP),…